Your browser doesn't support javascript.
Metodo LAMP como alternativa diagnostica para la deteccion del virus SARS-CoV-2
Revista Colombiana de Ciencias Quimico-Farmaceuticas(Colombia) ; 50(3):633-649, 2021.
Article Dans Anglais, Portugais, Espagnol | EMBASE | ID: covidwho-20243809
ABSTRACT
Summary

Introduction:

The SARS-CoV-2 coronavirus, that causes the COVID-19 disease, has become a global public health problem that requires the implementation of rapid and sensitive diagnostic tests. Aim(s) To evaluate and compare the sensitivity of LAMP assay to a standard method and use RT-LAMP for the diagnosis of SARS-CoV-2 in clinical samples from Colombian patients. Method(s) A descriptive and cross-sectional study was conducted. A total of 25 nasopharyngeal swab samples including negative and positive samples for SARS-CoV-2 were analyzed, through the RT-LAMP method compared to the RT-qPCR assay. Result(s) LAMP method detected ~18 copies of the N gene, in 30 min, evidenced a detection limit similar to the standard method, in a shorter time and a concordance in RT-LAMP of 100% with the results. Conclusion(s) RT-LAMP is a sensitive, specific, and rapid method that can be used as a diagnostic aid of COVID-19 disease.Copyright © 2021. All Rights Reserved.
Mots clés

Texte intégral: Disponible Collection: Bases de données des oragnisations internationales Base de données: EMBASE Type d'étude: Étude diagnostique / Études expérimentales / Étude observationnelle / Étude pronostique / Essai contrôlé randomisé langue: Anglais / Espagnol / Portugais Revue: Revista Colombiana de Ciencias Quimico-Farmaceuticas(Colombia) Année: 2021 Type de document: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Collection: Bases de données des oragnisations internationales Base de données: EMBASE Type d'étude: Étude diagnostique / Études expérimentales / Étude observationnelle / Étude pronostique / Essai contrôlé randomisé langue: Anglais / Espagnol / Portugais Revue: Revista Colombiana de Ciencias Quimico-Farmaceuticas(Colombia) Année: 2021 Type de document: Article